Registry for collecting oncology patient data
A Prospective Registry for Collecting Standardized, Routine Care Data to Characterize Patients, Treatment Patterns, Safety and Treatment Effectiveness in Adult Oncology Patients
This study is collecting information from cancer patients to help improve research and make it easier for them to join clinical trials.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20000 (estimated) |
| Ages | 18 Years to 120 Years |
| Sex | All |
| Sponsor | N-Power Medicine Industry-sponsored |
| Locations | 7 sites (Monterey, California and 6 other locations) |
| Trial ID | NCT06877884 on ClinicalTrials.gov |
What this trial studies
This observational registry collects standardized data from patients at various oncology centers. It includes information on baseline variables, treatments administered, and patient-reported outcomes through surveys. The goal is to create a comprehensive database that can facilitate patient participation in clinical trials and enhance research and development in oncology.
Who should consider this trial
Good fit: Ideal candidates are adult patients (18 years and older) receiving care at participating oncology centers who can provide informed consent.
Not a fit: Patients who are prisoners or unable to consent without a legally authorized representative may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could improve the understanding of cancer treatments and outcomes, leading to better patient care and more effective clinical trials.
How similar studies have performed: Other observational registries in oncology have shown success in improving data collection and patient engagement, making this approach promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Be a patient at a site (oncology) participating in the Registry Be at least 18 years old Be able and willing to provide signed informed consent Exclusion Criteria: Prisoners/imprisonment at time of screening for eligibility Patients who cannot consent without utilization of a legally authorized representative
Where this trial is running
Monterey, California and 6 other locations
- Pacific Cancer Care — Monterey, California, United States (Recruiting)
- Bayhealth Cancer Center-Kent — Dover, Delaware, United States (Recruiting)
- Bayhealth Cancer Center- Sussex — Milford, Delaware, United States (Recruiting)
- Northwest Oncology & Hematology — Elk Grove Village, Illinois, United States (Recruiting)
- New Mexico Oncology Hematology Consultants — Albuquerque, New Mexico, United States (Recruiting)
- Lankenau Medical Center — Paoli, Pennsylvania, United States (Recruiting)
- Oncology Consultants, P.A. — Houston, Texas, United States (Recruiting)
Study contacts
- Study coordinator: Christer Svedman, MD
- Email: support@npowermedicine.com
- Phone: 833-467-6734
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.